MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science focused on treating the root causes of diseases rather ...

Telomir Pharmaceuticals (TELO) announced findings from a preclinical progeria lifespan study conducted in collaboration with Nagi Bioscience SA. Utilizing C. elegans models, in which the study ...

A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...

Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1's effects on key drivers of accelerated aging There are an estimated 400-500 known cases worldwide, including ...

Explore the poignant journey of Sinenhlanhla Khoza, a mother battling Werner syndrome, as her story highlights the urgent ...

Sentynl will acquire full rights to the investigational drug candidate, Progerinin (SLC-D011), adding to its commercial portfolio of rare and ultra-rare disease products The agreement will allow ...

The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...

Can research into a rare, accelerated aging disease and "zombie cells" teach us something about the normal aging process? Did you know that a small molecule called NAD + plays a critical role in our ...

A new research paper was published in Volume 17, Issue 9 of Aging-US on August 27, 2025, titled, "Deregulated miR-145 and miR-27b in Hutchinson-Gilford progeria syndrome: implications for adipogenesis ...

Zach Pickard, a 17-year-old who had the rare rapid-aging disease progeria has died, his Lexington minister said in an online message to church members Sunday. Michael Swartzentruber, Senior Minister ...